| Name | Title | Contact Details |
|---|---|---|
Peter Wang |
Chief Technology Officer | Profile |
Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.
Affinity Medical Technology, LLC is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Danisco Venture (www.danisco.com/venture) is a corporate venture unit within Danisco A/S - one of the world's largest producers of ingredients for the food and feed industry.
General Systems Designs Inc is a Cedar Rapids, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Advantage Medical Equipment is a Carmel, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.